PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Approaches for optimal use of different COVID-19 vaccines

2021-03-04
(Press-News.org) What The Article Says: This Viewpoint proposes ways to maximize vaccine efficacy and allocation given the rise of coronavirus variants and authorization of a Johnson & Johnson vaccine, including reserving the latter for younger healthier populations, boosting it with a single-dose messenger RNA (mRNA) vaccination and single mRNA immunization of people with prior documented SARS-CoV-2 infection.

Authors: John P. Moore, Ph.D., of Weill Cornell Medicine in New York, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2021.3465)

Editor's Note: The article includes an Editor's Note. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

INFORMATION:

Media advisory: The full article is linked to this news release. A livestream with the author also is scheduled for Thursday at 3:50 P.M. (ET) and will be available here: http://ja.ma/moore0304

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.3465?guestAccessKey=a44d6501-b605-47f2-970e-f8cc12936363&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030421



ELSE PRESS RELEASES FROM THIS DATE:

Antisense oligonucleotides as a feasible therapy to treat MECP2 dupli

2021-03-04
Many cognitive neurodevelopmental disorders are a result of too many or too few copies of certain genes or chromosomes. To date, no treatment options exist for this class of disorders. MECP2 duplication syndrome (MDS) is one such disorder that primarily affects boys and results from a duplication spanning the methyl-CpG binding protein 2 (MECP2) locus located on the X chromosome. A preclinical study published from the laboratory of Dr. Huda Zoghbi, professor at Baylor College of Medicine and director of the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, provides experimental evidence that supports the use of antisense oligonucleotides as ...

Artificial intelligence reveals current drugs that may help combat Alzheimer's disease

2021-03-04
BOSTON - New treatments for Alzheimer's disease are desperately needed, but numerous clinical trials of investigational drugs have failed to generate promising options. Now a team at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) has developed an artificial intelligence-based method to screen currently available medications as possible treatments for Alzheimer's disease. The method could represent a rapid and inexpensive way to repurpose existing therapies into new treatments for this progressive, debilitating neurodegenerative condition. ...

Newly discovered millipede, Nannaria hokie, lives at Virginia Tech

Newly discovered millipede, Nannaria hokie, lives at Virginia Tech
2021-03-04
Hearing the words "new species discovered" may conjure images of deep caves, uncharted rainforests, or hidden oases in the desert. But the reality is that thousands of new species are discovered each year by enterprising scientists all over the world. Many of these new species do come from exotic locations, but more surprisingly, many come from just down the road, including the newest member of the Hokie Nation, the millipede Nannaria hokie. The newest Hokie -- which has about 60 more legs than the HokieBird ­-- was discovered living under rocks by the Duck Pond behind the Grove on Virginia Tech's Blacksburg campus. Since then, the critter has been found at the area commonly referred to as stadium ...

New evidence COVID-19 antibodies, vaccines less effective against variants

New evidence COVID-19 antibodies, vaccines less effective against variants
2021-03-04
New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus that cause COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic. With few exceptions, whether such antibodies were produced in response to vaccination or natural infection, or were purified antibodies intended for use as drugs, the researchers found more antibody is needed to neutralize the new variants. The findings, from laboratory-based experiments and published March 4 in Nature Medicine, suggest that COVID-19 drugs and vaccines developed thus far may become less effective ...

Smoking cessation drug may treat Parkinson's in women

2021-03-04
Texas A&M University College of Medicine ressearchers have recently discovered that cytisine -- a smoking cessation drug commonly used in Europe -- reduces the loss of dopamine neurons in females. These findings provide potential evidence for the use of the drug to treat Parkinson's disease or stop its progression in women. Sara Zarate and Gauri Pandey, graduate students from the lab of Rahul Srinivasan, assistant professor in the Department of Neuroscience & Experimental Therapeutics, are co-first authors of the research. Their findings are published in the Journal of Neurochemistry. There ...

Key enzymes for synthesizing natural products

2021-03-04
Plants, fungi, and bacteria produce natural products that function, among other things, as defenses that are deployed against predators and competitors. In medicine, these compounds are used for antibiotics, cancer drugs, and cholesterol reducers. The team working with associate professor Dr. Robin Teufel and Dr. Britta Frensch of the Institute of Biology II of the Faculty of Biology of the University of Freiburg was able, together with researchers from the ETH Zürich in Switzerland, to shed light on the key role of three enzymes that are involved in synthesizing a class of natural products. The researchers are publishing their findings in the latest edition of "Nature Communications." Actinobacteria produce many natural products, such as those that are ...

Will climate change outpace species adaptation?

2021-03-04
Many species might be left vulnerable in the face of climate change, unable to adapt their physiologies to respond to rapid global warming. According to a team of international researchers, species evolve heat tolerance more slowly than cold tolerance, and the level of heat they can adapt to has limits. In a study published in the Nature Communications, McGill professor Jennifer Sunday and her co-authors wanted to understand how species' thermal limits have evolved. To examine variation across the tree of life, the researchers developed the largest available database compiling thermal tolerances for all types of organisms (GlobTherm database). The ...

COVID-19 nasal swab test may not be best for those who've had sinus surgery

2021-03-04
SAN ANTONIO, March 4, 2021 -- People who have had major sinus surgery should consult their ENT doctor before undergoing COVID-19 swab testing, new research indicates. Likewise, those performing swab testing should ask whether the patient has had extensive sinus or skull base surgery, said END ...

Breaking the patrisharky: Scientists reexamine gender biases in shark, ray mating research

Breaking the patrisharky: Scientists reexamine gender biases in shark, ray mating research
2021-03-04
Shark scientists at Georgia Aquarium, Scripps Institution of Oceanography at UC San Diego, and Dalhousie University are challenging the status quo in shark and ray mating research in a new study that looks at biological drivers of multiple paternity in these animals. The results were published March 4 in the journal Molecular Ecology. Many species of sharks and rays exhibit multiple paternity, where females give birth to a litter of pups that have different fathers. While widely documented in scientific literature, the drivers of this phenomenon are not well understood. However, previous research has cited male aggression as ...

In professional athletes, heart risk after mild COVID-19 is very low, finds study

2021-03-04
NEW YORK, NY (March 4, 2021)--Inflammatory heart disease is a rare finding among professional athletes with mild or asymptomatic COVID-19 infection, a large-scale study has found. The study, led by Columbia University Vagelos College of Physicians and Surgeons in collaboration with the major North American sports leagues and their respective players' associations, was published online today in JAMA Cardiology. Athletes and COVID-19 Studies suggest that approximately 20% of patients hospitalized with severe COVID-19 develop some type of heart damage, but the impact of mild or asymptomatic ...

LAST 30 PRESS RELEASES:

How and when could AI be used in emergency medicine?

Report yields roadmap for Americans to age with health, wealth, and social equity

Pain research reveals new detail of how synapses strengthen

Hidden process behind 2025 Santorini earthquakes uncovered

Giant impactor Theia formed in the inner Solar System

Rebalancing lung repair with immune damage is key to surviving severe influenza

2025 Santorini seismic unrest triggered by “pumping” magma flow

Toxic gut bacteria may drive ulcerative colitis by killing protective immune cells

Rethinking where language comes from

Subverting plasmids to combat antibiotic resistance

Theia and Earth were neighbors

Calcium “waves” shape flies’ eyes

Scientists uncover new on-switch for pain signaling pathway that could lead to safer treatment and relief

Modeling of electrostatic and contact interaction between low-velocity lunar dust and spacecraft

Building a sustainable metals infrastructure: NIST report highlights key strategies

Discovering America’s ‘epilepsy belt’: First-of-its-kind national study reveals US regions with high epilepsy rates among older adults

Texting helps UCSF reach more patients with needed care

Working together to combat the spread of antibiotic resistance

Developing dehydration and other age-related conditions following major surgery linked to dramatically worse outcomes for older adults

Aged blood vessel cells drive metabolic diseases

This moss survived 9 months directly exposed to the elements of space

UC San Diego researchers develop new tool to predict how bacteria influence health

Prediction of optic disc edema progression during spaceflight

Age-based screening for lung cancer surveillance in the US

Study reveals long-term associations of strangulation-related brain injury from intimate partner violence

Monsoon storms will bring heavier rains but become weaker

New therapeutic strategies show promise against a hard-to-treat prostate cancer

Inflammatory biomarkers in ischemic stroke: mechanisms, clinical applications, and future directions

Grants to UC San Diego will boost roadway safety for Native American youth and pedestrians

Announcing the 2025 Mcknight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss: Leah Acker, MD, Ph.D., of Duke University and Erin Gibson, Ph.D., of the Stanford School of

[Press-News.org] Approaches for optimal use of different COVID-19 vaccines